세계의 신경혈관 스텐트 시장(2025-2033년)

The global neurovascular stents market reached US$ 1,251.75 million in 2024 and is expected to reach US$ 3,040.53 million by 2033, growing at a CAGR of 10.4% during the forecast period 2025-2033.

Neurovascular stents are small, mesh-like tubular devices implanted within brain blood vessels to treat various neurovascular conditions. They help restore normal blood flow by reinforcing weakened or narrowed arteries, reducing the risk of strokes and aneurysm ruptures. These stents come in different types, including intracranial stents for opening blocked brain arteries, flow diverters for large or wide-necked aneurysms, stent retrievers for removing blood clots in acute ischemic stroke, and carotid stents for preventing strokes caused by carotid artery stenosis.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurovascular Disorders

The rising prevalence of neurovascular disorders, such as stroke, aneurysms, and carotid artery disease, is significantly driving the growth of the neurovascular stents market. As the global population ages, the incidence of these conditions is increasing, particularly among older adults who are more vulnerable to cerebrovascular diseases.

The growing burden of ischemic strokes, which occur when blood flow to the brain is blocked, has led to a higher demand for neurovascular stents as a treatment option to restore blood flow and prevent further damage. For instance, according to a report by the National Institute of Health in 2025, it is stated that researchers estimate that approximately 795,000 people in the United States experience a stroke, with around 610,000 being first-time occurrences. Nearly 1 in 4 stroke survivors will suffer another stroke in their lifetime. Ischemic strokes, which occur due to blocked blood flow to the brain, account for about 87% of all stroke cases. Intracranial rescue stenting (RS) is an option for acute ischemic stroke after the failure of mechanical thrombectomy (MT). This increasing number of individuals with ischemic stroke individuals increases the need for neurovascular stenting procedures.

Additionally, the increasing number of patients suffering from intracranial atherosclerosis and intracranial aneurysms is fueling the adoption of stents designed to strengthen weakened blood vessels and reduce the risk of rupture.

High Cost of Neurovascular Stent Procedures

The high cost of neurovascular stent procedures is a significant barrier to market growth, particularly in developing regions where healthcare budgets and insurance coverage are limited. Neurovascular stents, along with the required imaging, surgical expertise, and post-procedure care, make the overall treatment expensive and the cost of the procedures varies depending on the complexity and location.

Segment Analysis

The global neurovascular stents market is segmented based on the type, material, application, end-user, and region.

Intracranial stents in the type segment is expected to dominate the neurovascular stents market

The intracranial stent segment is expected to dominate the global neurovascular stents market due to the rising incidence of ischemic strokes, intracranial atherosclerosis, and wide-necked aneurysms. As more patients suffer from cerebrovascular diseases, the demand for minimally invasive stenting solutions continues to grow. Intracranial stents provide a lifesaving alternative to traditional open surgeries, reducing recovery time and improving patient outcomes.

Technological advancements, such as drug-eluting and bioresorbable stents, are also driving adoption, as they help prevent complications like restenosis. Rising number of launches across various regions is expected to drive the segment's growth as these stents will be available for a vast range of individuals. For instance, in June 2024, MicroVention, Inc. announced the commercial launch of the LVIS EVO Intraluminal Support Device in the United States for the treatment of wide-neck intracranial aneurysms. The LVIS EVO, which has been available in Europe since 2019, has already seen over 12,000 units sold. Notably, it is the first fully visible coil-assist intracranial stent introduced to the U.S. market, marking a significant advancement in neurovascular treatment. Additionally, the aging global population is contributing to increased demand, as older adults are more susceptible to neurovascular conditions requiring stent placement.

Geographical Analysis

North America is expected to dominate the neurovascular stents market

North America is expected to dominate the global neurovascular stents market due to several key factors. The region has a high prevalence of neurovascular diseases, including stroke, aneurysms, and intracranial atherosclerosis, driving demand for advanced treatment options like neurovascular stents. For instance, according to the Brain Aneurysm Foundation, with approximately 1 in 50 people in the United States affected by brain aneurysms and an estimated 6.7 million Americans living with an unruptured aneurysm, the demand for neurovascular stents continues to rise, as around 30,000 individuals suffer a rupture each year, increasing the need for advanced neurovascular interventions to prevent life-threatening complications and driving the neurovascular stents market in North America.

The aging population further contributes to this demand, as older adults are at a higher risk of cerebrovascular conditions. The presence of leading medical device companies ensures continuous innovation and a strong pipeline of technologically advanced stents, including drug-eluting and bioresorbable stents. Additionally, well-established healthcare infrastructure, including specialized neurology centers and stroke care units, supports faster adoption of neurovascular stents in hospitals and clinics.

Competitive Landscape

The global market players in the neurovascular stents market are Stryker, Acandis GmbH, Balt Group, Boston Scientific Corporation, Terumo Corporation and MicroPort Scientific Corporation among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
• Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global neurovascular stents market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

• Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type
• 2.4. Snippet by Material
• 2.5. Snippet by Application
• 2.6. Snippet by End-User
• 2.7. Snippet by Region

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising Prevalence of Neurovascular Disorders
    • 3.1.1.2. Advancements in Stent Technology
  • 3.1.2. Restraints
    • 3.1.2.1. High Cost of Neurovascular Stent Procedures
    • 3.1.2.2. Stringent Regulatory Approval Processes
  • 3.1.3. Opportunity
    • 3.1.3.1. Rising Demand for Minimally Invasive Procedures
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia Pacific
  • 4.5.4. Latin America
  • 4.5.5. Middle East & Africa
• 4.6. Porter's Five Force Analysis
• 4.7. Supply Chain Analysis
• 4.8. Patent Analysis
• 4.9. SWOT Analysis
• 4.10. Unmet Needs and Gaps
• 4.11. Recommended Strategies for Market Entry and Expansion
• 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.13. Pricing Analysis and Price Dynamics
• 4.14. Key Opinion Leaders

5. Neurovascular Stents Market, By Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 5.1.2. Market Attractiveness Index, By Type
• 5.2. Intracranial Stents*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Carotid Artery Stents

6. Neurovascular Stents Market, By Material

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 6.1.2. Market Attractiveness Index, By Material
• 6.2. Polymers*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Metal
• 6.4. Others

7. Neurovascular Stents Market, By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Carotid Artery Stenosis*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Cerebral Aneurysms
• 7.4. Arteriovenous Malformations and Fistulas
• 7.5. Others

8. Neurovascular Stents Market, By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ambulatory Surgical Centers
• 8.4. Specialty Clinics

9. Neurovascular Stents Market, By Regional Market Analysis and Growth Opportunities

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.7.1. U.S.
    • 9.2.7.2. Canada
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.7.1. Germany
    • 9.3.7.2. U.K.
    • 9.3.7.3. France
    • 9.3.7.4. Spain
    • 9.3.7.5. Italy
    • 9.3.7.6. Rest of Europe
• 9.4. Latin America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.7.1. Mexico
    • 9.4.7.2. Brazil
    • 9.4.7.3. Argentina
    • 9.4.7.4. Rest of Latin America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.7.1. China
    • 9.5.7.2. India
    • 9.5.7.3. Japan
    • 9.5.7.4. South Korea
    • 9.5.7.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

• 10.1. Competitive Overview and Key Market Players
• 10.2. Market Share Analysis and Positioning Matrix
• 10.3. Strategic Partnerships, Mergers & Acquisitions
• 10.4. Key Developments in Product Portfolios and Innovations
• 10.5. Company Benchmarking

11. Company Profiles

• 11.1. Stryker*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals, etc.
  • 11.1.5. SWOT Analysis
• 11.2. Acandis GmbH
• 11.3. Balt Group
• 11.4. Boston Scientific Corporation
• 11.5. Terumo Corporation
• 11.6. MicroPort Scientific Corporation

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

• 12.1. Data Collection Methods
• 12.2. Data Triangulation
• 12.3. Forecasting Techniques
• 12.4. Data Verification and Validation

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us